Shuangling Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shuangling Luo has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Huashan Liu
Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
20 shared publications - Li Xiong
Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
20 shared publications - Liang Huang
Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
20 shared publications - Liang Kang
Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
20 shared publications - Renhan Luo
Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
20 shared publications - Shaoru Liu
Sun Yat-sen University Cancer Center 3 Guangzhou
20 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S10 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Significantly differentially expressed genes identified in tryptophan treated B cells compared to DMSO treated B cells with irradiation treatment
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S10 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Significantly differentially expressed genes identified in tryptophan treated B cells compared to DMSO treated B cells with irradiation treatment
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
SIRT1 restricts the accumulation of cytoplasmic RNA:DNA hybrid induced by irradiation to prevent cGAS/STING signaling activation
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
SIRT1 restricts the accumulation of cytoplasmic RNA:DNA hybrid induced by irradiation to prevent cGAS/STING signaling activation
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Competitive uptake of tryptophan by cancer cells inhibits the formation of TLS with irradiation
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Competitive uptake of tryptophan by cancer cells inhibits the formation of TLS with irradiation
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
All antibodies used in the study
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
All antibodies used in the study
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Primers used for qPCR assay in present study
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Primers used for qPCR assay in present study
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Radiotherapy forces a tryptophan-SIRT1-SLC36A4 feedback to further enhance SIRT1 activity and competitively uptake tryptophan in TME
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Radiotherapy forces a tryptophan-SIRT1-SLC36A4 feedback to further enhance SIRT1 activity and competitively uptake tryptophan in TME
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Tryptophan deficiency inhibits B cell activation and TLS formation through suppressing TCA cycle
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Tryptophan deficiency inhibits B cell activation and TLS formation through suppressing TCA cycle
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Significantly differentially expressed genes identified in SIRT1-KO cells compared to control cells with irradiation treatment
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Significantly differentially expressed genes identified in SIRT1-KO cells compared to control cells with irradiation treatment
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Primers used for ChIP assay in present study
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Primers used for ChIP assay in present study
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Acetyl-CoA induced elevation in global lysine acetylation level was associated with better response to radioimmunotherapy in MSS rectal cancer
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from SIRT1 Inhibits T-cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance
Acetyl-CoA induced elevation in global lysine acetylation level was associated with better response to radioimmunotherapy in MSS rectal cancer